Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours

Neuropathology and Applied Neurobiology

Volumn 33, Issue 1, 2007, Pages 77-85

  Reed, J E ^a,b   Dunn, J R ^a   Du Plessis, D G ^b   Shaw, E J ^a   Reeves, P ^b   Gee, A L ^a   Warnke, P C ^b   Sellar, G C ^c   Moss, D J ^b   Walker, C ^a  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Brain tumours; Cell adhesion molecule; Glioblastoma; Glioma; IgLON; OPCML (OBCAM)

Indexed keywords

CELL ADHESION MOLECULE; PRIMER RNA;

ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FRONTAL LOBE; GENE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDULLOBLASTOMA; MENINGIOMA; MENINX; METASTASIS; NUCLEOTIDE SEQUENCE; OPCML GENE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; STATISTICAL SIGNIFICANCE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BRAIN NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DNA, COMPLEMENTARY; DOWN-REGULATION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; METHYLATION; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 33846128135     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00786.x     Document Type: Article

References (36)

1. Eagleson KL, Pimenta AF, Burns MM, Fairfull LD, Cornuet PK, Zhang L, Levitt P. Distinct domains of the limbic system-associated membrane protein (LAMP) mediate discrete effects on neurite outgrowth. Mol Cell Neurosci 2003; 24: 725-40
2. Funatsu N, Miyata S, Kumanogoh H, Shigeta M, Hamada K, Endo Y, Sokawa Y, Maekawa S. Characterization of a novel rat brain glycosylphosphatidylinositol- anchored protein (Kilon), a member of the IgLON cell adhesion molecule family. J Biol Chem 1999; 274: 8224-30
3. Gil OD, Zanazzi G, Struyk AF, Salzer JL. Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions. J Neurosci 1998; 18: 9312-25
4. McNamee CJ, Reed JE, Howard MR, Lodge AP, Moss DJ. Promotion of neuronal cell adhesion by members of the IgLON family occurs in the absence of either support or modification of neurite outgrowth. J Neurochem 2002; 80: 941-8
5. Wilson DJ, Kim DS, Clarke GA, Marshall-Clarke S, Moss DJ. A family of glycoproteins (GP55), which inhibit neurite outgrowth, are members of the Ig superfamily and are related to OBCAM, neurotrimin, LAMP and CEPU-1. J Cell Sci 1996; 109: 3129-38
6. Schafer M, Brauer AU, Savaskan NE, Rathjen FG, Brummendorf T. Neurotractin/kilon promotes neurite outgrowth and is expressed on reactive astrocytes after entorhinal cortex lesion. Mol Cell Neurosci 2005; 29: 580-90
7. Gil OD, Zhang L, Chen S, Ren YQ, Pimenta A, Zanazzi G, Hillman D, Levitt P, Salzer JL. Complementary expression and heterophilic interactions between IgLON family members neurotrimin and LAMP. J Neurobiol 2002; 51: 190-204
8. Lodge AP, Howard MR, McNamee CJ, Moss DJ. Colocalisation, heterophilic interactions and regulated expression of IgLON family proteins in the chick nervous system. Brain Res Mol Brain Res 2000; 82: 84-94
9. Marg A, Sirim P, Spaltmann F, Plagge A, Kauselmann G, Buck F, Rathjen FG, Brummendorf T. Neurotractin, a novel neurite outgrowth-promoting Ig-like protein that interacts with CEPU-1 and LAMP. J Cell Biol 1999; 145: 865-76
10. Zhukareva V, Levitt P. The limbic system-associated membrane protein (LAMP) selectively mediates interactions with specific central neuron populations. Development 1995; 121: 1161-72
11. Reed J, McNamee C, Rackstraw S, Jenkins J, Moss D. Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells. J Cell Sci 2004; 117: 3961-73
12. Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, Massie CE, Miller J, Contreras-Moreira B, Scott D, Brown I, Williams AR, Bates PA, Smyth JF, Gabra H. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet 2003; 34: 337-43
13. Mei FC, Young TW, Liu J, Cheng X. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J 2006; 20: 497-9
14. Ntougkos E, Rush R, Scott D, Frankenberg T, Gabra H, Smyth JF, Sellar GC. The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates. Clin Cancer Res 2005; 11: 5764-8
15. Chen J, Lui WO, Vos MD, Clark GJ, Takahashi M, Schoumans J, Khoo SK, Petillo D, Lavery T, Sugimura J, Astuti D, Zhang C, Kagawa S, Maher ER, Larsson C, Alberts AS, Kanayama HO, Teh BT. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 2003; 4: 405-13
16. Kleihues P, Cavanee W, eds. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press, 2000
17. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003; 361: 323-31
18. Reardon DA, Rich JN, Friedman HS, Bigner DD. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 2006; 24: 1253-65
19. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003; 21: 1624-36
20. Kuriyama H, Lamborn KR, O'Fallon JR, Iturria N, Sebo T, Schaefer PL, Scheithauer BW, Buckner JC, Kuriyama N, Jenkins RB, Israel MA. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas. Neuro-Oncol 2002; 4: 179-86
21. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005; 23: 2411-22
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 2001; 25: 402-8
23. Dunn JR, Reed JE, du Plessis DG, Shaw EJ, Reeves P, Gee AL, Warnke P, Walker C. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 2006; 94: 1186-93
24. Hachisuka A, Nakajima O, Yamazaki T, Sawada J. Developmental expression of opioid-binding cell adhesion molecule (OBCAM) in rat brain. Brain Res Dev Brain Res 2000; 122: 183-91
25. Li P, Prasad SS, Mitchell DE, Hachisuka A, Sawada JI, Al-Housseini AM, Gu Q. Postnatal expression profile of OBCAM implies its involvement in visual cortex development and plasticity. Cereb Cortex 2006; 16: 291-9
26. Miyata S, Matsumoto N, Taguchi K, Akagi A, Iino T, Funatsu N, Maekawa S. Biochemical and ultrastructural analyses of IgLON cell adhesion molecules, Kilon and OBCAM in the rat brain. Neuroscience 2003; 117: 645-58
27. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004; 36: 1046-69
28. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004; 70: 217-28
29. Tews DS, Nissen A. Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors. Invasion Metastasis 1998; 18: 271-84
30. Tews DS. Adhesive and invasive features in gliomas. Pathol Res Pract 2000; 196: 701-11
31. Maenpaa A, Kovanen PE, Paetau A, Jaaskelainen J, Timonen T. Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomas. Acta Neuropathol (Berl) 1997; 94: 216-25
32. Gingras MC, Roussel E, Bruner JM, Branch CD, Moser RP. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol 1995; 57: 143-53
33. Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, Aldape HC, Simrell CR, Murphy GP. Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int J Cancer 1998; 76: 451-8
34. Sasaki H, Yoshida K, Ikeda E, Asou H, Inaba M, Otani M, Kawase T. Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy. Cancer 1998; 82: 1921-31
35. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8
36. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005; 7: 7-16